Development of novel self-assembled DS-PLGA hybrid nanoparticles for improving oral bioavailability of vincristine sulfate by P-gp inhibition.
about
Engineering Biomaterial-Drug Conjugates for Local and Sustained Chemotherapeutic DeliveryDrug delivery systems and combination therapy by using vinca alkaloidsCancer optical imaging using fluorescent nanoparticles.Improved brain delivery of vincristine using dextran sulfate complex solid lipid nanoparticles: optimization and in vivo evaluation.Preparation and characterization of magnetic alginate-chitosan hydrogel beads loaded matrine.Formulation and optimization of itraconazole polymeric lipid hybrid nanoparticles (Lipomer) using Box Behnken design.A nanohybrid system for taste masking of sildenafil.Nano-advantage in enhanced drug delivery with biodegradable nanoparticles: contribution of reduced clearance.Engineering the lipid layer of lipid-PLGA hybrid nanoparticles for enhanced in vitro cellular uptake and improved stability.A novel submicron emulsion system loaded with vincristine-oleic acid ion-pair complex with improved anticancer effect: in vitro and in vivo studies.Synergistic and complete reversal of the multidrug resistance of mitoxantrone hydrochloride by three-in-one multifunctional lipid-sodium glycocholate nanocarriers based on simultaneous BCRP and Bcl-2 inhibition.Drug-Loaded Polymeric Nanoparticles for Cancer Stem Cell Targeting.Enhancing the oral bioavailability of biochanin A by encapsulation in mixed micelles containing Pluronic F127 and Plasdone S630.The holistic 3M modality of drug delivery nanosystems for cancer therapy.Concepts and practices used to develop functional PLGA-based nanoparticulate systemsAdvances in P-glycoprotein-based approaches for delivering anticancer drugs: pharmacokinetic perspective and clinical relevance.Therapeutic potential of nanocarrier for overcoming to P-glycoprotein.Lipid polymer hybrid as emerging tool in nanocarriers for oral drug delivery.Hyaluronic acid-coated cationic nanostructured lipid carriers for oral vincristine sulfate delivery.Lysozyme-loaded lipid-polymer hybrid nanoparticles: preparation, characterization and colloidal stability evaluation.Nanostructured lipid-carrageenan hybrid carriers (NLCCs) for controlled delivery of mitoxantrone hydrochloride to enhance anticancer activity bypassing the BCRP-mediated efflux.Preparation and cellular targeting study of VEGF-conjugated PLGA nanoparticles.Preparation of vincristine sulfate-loaded poly (butylcyanoacrylate) nanoparticles modified with pluronic F127 and evaluation of their lymphatic tissue targeting.Targeted delivery of nano-PTX to the brain tumor-associated macrophagesIn vitro cytotoxicity and bioavailability of solid lipid nanoparticles containing tamoxifen citrate.Enhancement of oral bioavailability of cyclosporine A: comparison of various nanoscale drug-delivery systems.Hybrid nanoparticles for the topical delivery of norfloxacin for the effective treatment of bacterial infection produced after burn.The role of lipid-based nano delivery systems on oral bioavailability enhancement of fenofibrate, a BCS II drug: comparison with fast-release formulations.Single-step assembly of polymer-lipid hybrid nanoparticles for mitomycin C delivery.Preparation of pixantrone/poly(γ-glutamic acid) nanoparticles through complex self-assembly for oral chemotherapy.Targeted Therapeutic Nanoparticles: An Immense Promise to Fight against Cancer.Comparison of hyaluronic acid-based micelles and polyethylene glycol-based micelles on reversal of multidrug resistance and enhanced anticancer efficacy in vitro and in vivo.Development of docetaxel nanocapsules for improving in vitro cytotoxicity and cellular uptake in MCF-7 cells.Lipid-polymer hybrid nanoparticles: Development & statistical optimization of norfloxacin for topical drug delivery system.Nanotechnology as Emerging Tool for Enhancing Solubility of Poorly Water-Soluble DrugsChitosan-functionalized lipid-polymer hybrid nanoparticles for oral delivery of silymarin and enhanced lipid-lowering effect in NAFLDRecent Trends in Preparation of Poly(lactide-co-glycolide) Nanoparticles by Mixing Polymeric Organic Solution with Antisolvent
P2860
Q28087367-BC767A29-C07C-41ED-8F76-CF87C6116D49Q28829009-4AF11E60-5CEB-41AF-BB51-48D67929E976Q30471819-64DFF33C-CB68-43AB-80D5-1B73C09B453BQ30657827-B8DC3394-642E-46D7-9A0A-D7694734A39CQ34076504-403368EA-18E3-4D4F-ACCC-06B5C6B10B61Q35033387-C9ABAC13-4507-49E8-BF3C-A588BF426565Q35972590-865D3B8F-C9A6-40B2-9D1A-70E09330FE02Q36057394-D46CA709-9A49-4956-8C9E-CA617F9F97AFQ36289194-084D32CC-7FB0-4F28-840B-210CDFEE433FQ36714048-D5B598D8-7A28-49F4-A7FA-3ABEC819AB15Q37214483-2DF8C21A-B11D-4A3B-87AD-E57A30FBA8E8Q37639772-8081272F-5FEA-47B9-8AD0-CC809D1AB6C4Q37670038-AC0C60E9-792F-4472-8580-40BD2FD802FFQ38071901-DBA23056-1EA6-4445-8076-833F2F05E67EQ38086377-24341F2E-6FF6-4D6E-9CAE-EC522A2F30FAQ38167822-FAFFD9F1-E3F2-4130-A6B8-AF29EC172252Q38237724-1DE9C233-8469-41F2-834D-D19B7E2597CEQ38252593-B6738F0C-6E8D-42F1-9D55-D1AD572146F6Q38723241-464E4446-9359-4038-AADE-EBE89D221348Q38777279-54D8F962-6EF2-49FA-9E90-389425D8E8CEQ38804702-6DE300FD-6540-423D-8E8A-5CFC41030126Q38871484-50A8A618-7E77-4E1D-94D4-D765DA95F3C5Q39015939-AD5D1D41-F9B1-456C-B8C4-66F81EEB3B9AQ39050920-F9CF678D-A90C-4F66-AC04-7CC5899B00F3Q39096524-2D594B97-CB52-46CB-96B5-EF6EB261EE67Q39574444-B02B86A6-6C11-41B0-8F65-BC23C4238F2EQ40191150-E8A177E9-648C-4760-9BE2-00AB53ADB9D7Q41889403-7B1C6FD2-F7C4-4789-B87B-D7A50934EA00Q42117333-80136AED-E118-408C-82E6-D94C8FFA0293Q42830319-ADC78CB4-CB70-47E0-8C69-703175B0C0EBQ49787181-76BCF5C5-2F98-464F-B1DF-31AAFA797119Q49927967-1989F76A-7045-49B4-B7C2-0FEABD87EDC5Q53614518-75B45357-0FC5-4ED3-91C5-DA970DCE5F61Q55220123-38A06CEC-6905-4E1B-A35D-CDE5A1D6B3E0Q57343790-18F39FDE-455D-42CF-8EC4-A6CBB28AE4A4Q58765669-112A13F5-B176-4D23-866C-6656C211EAE4Q59113665-045B3E91-FECB-41BF-9C41-9E27A75CCD90
P2860
Development of novel self-assembled DS-PLGA hybrid nanoparticles for improving oral bioavailability of vincristine sulfate by P-gp inhibition.
description
2010 nî lūn-bûn
@nan
2010年の論文
@ja
2010年論文
@yue
2010年論文
@zh-hant
2010年論文
@zh-hk
2010年論文
@zh-mo
2010年論文
@zh-tw
2010年论文
@wuu
2010年论文
@zh
2010年论文
@zh-cn
name
Development of novel self-asse ...... ne sulfate by P-gp inhibition.
@en
Development of novel self-asse ...... ne sulfate by P-gp inhibition.
@nl
type
label
Development of novel self-asse ...... ne sulfate by P-gp inhibition.
@en
Development of novel self-asse ...... ne sulfate by P-gp inhibition.
@nl
prefLabel
Development of novel self-asse ...... ne sulfate by P-gp inhibition.
@en
Development of novel self-asse ...... ne sulfate by P-gp inhibition.
@nl
P2093
P1476
Development of novel self-asse ...... ne sulfate by P-gp inhibition.
@en
P2093
Guixia Ling
Peng Zhang
Wenping Zhang
Xiaoxue Meng
Yihui Deng
Yimeng Qin
Zhonggui He
P304
P356
10.1016/J.JCONREL.2010.08.010
P407
P577
2010-08-18T00:00:00Z